期刊文献+

帕瑞昔布对老年全髋关节置换术患者的术后镇痛效果 被引量:2

Effects of postoperative analgesia with parecoxib on the elderly patients after total replacement of hip joint
原文传递
导出
摘要 目的评价帕瑞昔布对老年全髋关节置换术患者术后镇痛的效果及对血液动力学的影响。方法全髋关节置换术患者50例,年龄65~75岁,随机分成两组:帕瑞昔布组和对照组,分别单次静脉注射帕瑞昔布40mg或等容量生理盐水。常规监测平均动脉压、心率。在患者离开手术室前、术后1、6h时评估和记录患者的疼痛评分。结果两组患者术中血液动力学指标差异无统计学意义(P〉O.05);与对照组相比,帕瑞昔布组术后各时点VAS评分较低,术后需要追加镇痛药的平均时间较长,例数较少(P〈o.05)。结论静脉注射帕瑞昔布40mg可在不影响血液动力学的基础上有效地缓解老年全髋关节置换术患者的术后疼痛。 Objective To evaluate the effects of parecoxib on postoperative analgesia and hae- modynamic status for patients after total replacement of hip joint. Methods Fifty patients with total hip joint replacement, aged 65 - 75 years were randomly assigned to parecoxib group and control group, with single dose of intravenous parecoxib 40 mg and same volume of normal saline respective- ly. Heart rate, mean arterial pressure were monitored. VAS was recorded before leaving the operat- ing room, and 1 h and 6 h after the operation. Results There was no difference in haemodynamic in- dexes between the two groups (P^0.05). Compared with control group, VAS was low in parecoxib group. Average time of postoperative additional analgesics was longer in parecoxib group than that in control group (P(0.05). Conclusion Intravenous injection of parecoxib 40 mg can relieve postoper- ative pain and not influence the haemodynamics for elderly patients after total replacement of hip joint.
出处 《实用疼痛学杂志》 2012年第3期205-207,共3页 Pain Clinic Journal
关键词 环氧化酶2抑制剂 疼痛 手术后 镇痛 Cyclooxygenase 2 inhibitors ~ Pain, postoperative Analgesia
  • 相关文献

参考文献7

  • 1timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery. Anesth Analg, 2007, 104 (6) : 1521 -1527.
  • 2吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 3Desjardins PJ, Shu VS, Recker DP, et al. A single preopera- tive oral dose of valdecoxib, a new cyclooxygenase-2 specificinhibitor, relieves post-oral surgery or bunionectomy pain. Anesthesiology, 2002, 97(3):565-573.
  • 4Viscusi ER, Gimbel JS, Halder AM, et al. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty. Anesth Analg, 2008, 107 (2) :652-660.
  • 5Gan TJ, Joshi GP, Zhao SZ, et al. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain man- agement after laparoscopie cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiol Seand, 2004, 48(9): 119-1207.
  • 6罗莹,张海峰,朱立光,刘和昌.帕瑞昔布用于下肢及腹部手术术后镇痛对节约吗啡用量的系统评价[J].广西医学,2008,30(6):799-802. 被引量:9
  • 7Gardiner SM, March JE, Kemp PA, et al. Effects of nitric ox- ide synthase inhibition with or without cyclooxygenase-2 inhi- bition on resting haemodynamics and responses to exendin-4. BrJPharmacol, 2006, 149(6) :802-809.

二级参考文献24

  • 1吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 2McArdle P. Intravenous analgesia. Crit Care Clin, 1999,15:89-104.
  • 3Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anesthesia. Drug Saf, 1998,19:173-189.
  • 4Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia"in postoperative pain treatment. Anesth Analg, 1993,77:1048-1056.
  • 5Power I, Barrett S. Analgesic agents for the postoperative period: nonopioids. Surg Clin North Am, 1999,79:275-295.
  • 6Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am, 1999,79:401-430.
  • 7Lipsky LP, Abramson SB, Crefford L, et al. The classification of cyclooxygenase inhibitors. J Rheumatol, 1998,25:2298-2303.
  • 8Penning TD, Talley JJ, Berteushaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenuse-2 inhihitors:identification of 4- [ 5- ( 4-methylphenyl ) -3- ( trifluoremethyl )- 1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem, 1997,40:1347-1365.
  • 9Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenuse type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002,96: 1305-1309.
  • 10Malan TP Jr,Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenuse 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology, 2003,98 :950-956.

共引文献368

同被引文献52

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部